Skip to main content

Table 1 Clinical, demographic, and laboratory data

From: Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis

Variables

Healthy individuals (N = 30)

Values, mean ± SD or n/N (%)

Patients on HD (N = 78)

Values, mean ± SD or n/N (%)

Age (years)

48.3 ± 8.15

69.9 ± 10.7

Sex (female)

19/30 (63.3%)

34/78 (43.6%)

Body mass index (kg/m2)

22.2 ± 3.30

22.8 ± 4.69

Diabetes mellitus

0/30 (0%)

32/78 (41.0%)

Hemoglobin (g/dL)

14.0 ± 1.43

10.9 ± 1.28

Albumin (g/dL)

4.56 ± 0.263

3.62 ± 0.356

Aspartate aminotransferase (IU/L)

23.5 ± 9.78

14.2 ± 7.26

Alanine aminotransferase (IU/L)

21.5 ± 10.3

12.0 ± 6.74

Urea nitrogen (mg/dL)

13.0 ± 3.32

65.4 ± 15.9

Creatinine (mg/dL)

0.726 ± 0.157

10.6 ± 2.97

Uric acid (mg/dL)

5.01 ± 1.40

6.05 ± 1.42

Corrected calcium (mg/dL)a

9.35 ± 0.316

9.09 ± 0.568

Inorganic phosphorus (mg/dL)

3.35 ± 0.366

5.22 ± 1.48

Iron (μg/dL)

99.6 ± 33.8

69.8 ± 27.9

C-reactive protein (mg/dL)

0.0267 ± 0.0645

0.281 ± 0.671

  1. aCorrected calcium: total serum calcium corrected for serum albumin. HD, hemodialysis